AR076731A1 - Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas - Google Patents
Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticasInfo
- Publication number
- AR076731A1 AR076731A1 ARP090101651A ARP090101651A AR076731A1 AR 076731 A1 AR076731 A1 AR 076731A1 AR P090101651 A ARP090101651 A AR P090101651A AR P090101651 A ARP090101651 A AR P090101651A AR 076731 A1 AR076731 A1 AR 076731A1
- Authority
- AR
- Argentina
- Prior art keywords
- ono2
- alkoxy
- same
- alkyl
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 2
- 229910004679 ONO2 Inorganic materials 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000006545 (C1-C9) alkyl group Chemical group 0.000 abstract 2
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 abstract 2
- 206010018307 Glaucoma and ocular hypertension Diseases 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5208408P | 2008-05-09 | 2008-05-09 | |
| US13933308P | 2008-12-19 | 2008-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR076731A1 true AR076731A1 (es) | 2011-07-06 |
Family
ID=41020929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101651A AR076731A1 (es) | 2008-05-09 | 2009-05-07 | Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8101658B2 (enExample) |
| EP (1) | EP2274279B1 (enExample) |
| JP (1) | JP5401540B2 (enExample) |
| CN (1) | CN102099330B (enExample) |
| AR (1) | AR076731A1 (enExample) |
| CA (1) | CA2723704C (enExample) |
| ES (1) | ES2428387T3 (enExample) |
| WO (1) | WO2009136281A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6087147B2 (ja) * | 2009-06-22 | 2017-03-01 | ジョンソン、マッセイ、パブリック、リミテッド、カンパニーＪｏｈｎｓｏｎ Ｍａｔｔｈｅｙ Ｐｕｂｌｉｃ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ | プロスタグランジンの精製方法 |
| WO2012112451A1 (en) * | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Ester derivatives of bimatoprost compositions and methods |
| US20150272988A1 (en) | 2012-03-07 | 2015-10-01 | Advanced Inhalation Therapies (Ait) Ltd. | Inhalation of nitric oxide for treating respiratory diseases |
| CA2871292A1 (en) | 2012-05-31 | 2013-12-05 | Theravance Biopharma R&D Ip, Llc | Nitric oxide donor neprilysin inhibitors |
| US10280138B2 (en) | 2015-03-31 | 2019-05-07 | Nicox S.A. | Nitric oxide donating derivatives of fluprostenol |
| US10047047B2 (en) | 2015-03-31 | 2018-08-14 | Nicox S.A. | Nitric oxide donating derivatives of latanoprost free acid |
| EP3088388A1 (en) | 2015-04-30 | 2016-11-02 | NicOx S.A. | Nitric oxide donating derivatives of prostaglandins |
| EP3347096A4 (en) | 2015-09-09 | 2019-05-15 | Advanced Inhalation Therapies (AIT) Ltd. | STICK OXIDE INHALATION THERAPY FOR SMALL CHILDREN WITH BRONCHIOLITIS |
| BR112019009330A2 (pt) | 2016-11-08 | 2019-07-30 | Bausch & Lomb | composto |
| ES2836118T3 (es) * | 2018-02-21 | 2021-06-24 | Nicox Sa | Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico |
| RU2718744C2 (ru) | 2018-05-17 | 2020-04-14 | Общество с ограниченной ответственностью "Гурус БиоФарм" | Производные простагландина F2альфа для снижения внутриглазного давления |
| US10688073B2 (en) * | 2018-07-12 | 2020-06-23 | Nicox Sa | Ophthalmic compositions containing a nitric oxide releasing prostamide |
| EP3772511B1 (en) * | 2019-08-05 | 2023-11-08 | Nicox S.A. | Process for the preparation of a nitric oxide donating prostaglandin analogue |
| ES3017242T3 (en) * | 2021-02-03 | 2025-05-12 | Nicox Sa | Process for the preparation of a nitric oxide donating prostaglandin analogue |
| US20240390390A1 (en) | 2021-09-20 | 2024-11-28 | Nicox Sa | Nitric oxide releasing prostamide as neuroprotective agent |
| CN119350280A (zh) * | 2021-11-18 | 2025-01-24 | 广州楷石医药有限公司 | 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途 |
| EP4410294A3 (en) | 2022-07-07 | 2024-11-06 | Nicox S.A. | Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product |
| CN115677549A (zh) * | 2022-10-27 | 2023-02-03 | 神隆医药（常熟）有限公司 | 一种贝美前列素手性异构体的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US6395787B1 (en) * | 2000-02-08 | 2002-05-28 | Allergan Sales, Inc. | Ocular hypotensive lipids |
| TWI298257B (en) * | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
| EP1336602A1 (en) * | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| EP1480949B1 (en) * | 2002-03-01 | 2015-04-29 | Allergan, Inc. | Preparation of prostamides |
| JP3984283B2 (ja) * | 2004-01-05 | 2007-10-03 | ニコックス，ソシエテ アノニム | プロスタグランヂンニトロオキシ誘導体 |
| WO2007000641A2 (en) * | 2005-06-29 | 2007-01-04 | Pfizer Inc. | Prostaglandin derivatives |
| US20070015838A1 (en) * | 2005-07-14 | 2007-01-18 | Allergan, Inc. | Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
-
2009
- 2009-05-07 AR ARP090101651A patent/AR076731A1/es active IP Right Grant
- 2009-05-11 ES ES09742454T patent/ES2428387T3/es active Active
- 2009-05-11 WO PCT/IB2009/005594 patent/WO2009136281A1/en not_active Ceased
- 2009-05-11 CA CA2723704A patent/CA2723704C/en active Active
- 2009-05-11 CN CN200980127115.4A patent/CN102099330B/zh active Active
- 2009-05-11 JP JP2011508009A patent/JP5401540B2/ja active Active
- 2009-05-11 EP EP09742454.3A patent/EP2274279B1/en active Active
- 2009-05-11 US US12/991,855 patent/US8101658B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5401540B2 (ja) | 2014-01-29 |
| US20110092590A1 (en) | 2011-04-21 |
| CN102099330A (zh) | 2011-06-15 |
| EP2274279A1 (en) | 2011-01-19 |
| US8101658B2 (en) | 2012-01-24 |
| ES2428387T3 (es) | 2013-11-07 |
| HK1160835A1 (en) | 2012-08-17 |
| EP2274279B1 (en) | 2013-07-31 |
| CA2723704A1 (en) | 2009-11-12 |
| CN102099330B (zh) | 2014-04-30 |
| WO2009136281A1 (en) | 2009-11-12 |
| CA2723704C (en) | 2017-08-22 |
| JP2011519910A (ja) | 2011-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR076731A1 (es) | Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas | |
| ECSP10010556A (es) | Piridinas y pirazinas como inhibidores de pi3k | |
| MA34916B1 (fr) | Nouveaux dérivés d'azabenzimidazole cyclique utiles en tant qu'agents antidiabétiques | |
| MA32175B1 (fr) | Oxadiazoanthracènes pour le traitement du diabète | |
| EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
| AR045900A1 (es) | Compuesto glucocorticoesteroide, composiciones farmaceuticas que los contienen y su uso para el tratamiento de trastornos inflamatorios y/o alergicos. | |
| AR047081A1 (es) | Derivados de prostaglandinas, metodos para su preparacion, composiciones farmaceuticas que las contienen y su uso en el tratamiento del glaucoma y de la hipertension ocular. | |
| UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
| PE20171648A1 (es) | Tratamiento combinado con un agonista de tlr7 y un inhibidor del ensamblaje de la capsida del vhb | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| PE20220017A1 (es) | Inhibidores del kcnt1 y metodos de uso | |
| AR074359A1 (es) | Compuestos heterociclicos sustituidos como moduladores de canales ionicos | |
| AR043508A1 (es) | 1-amino 1-h-imidazoquinolinas y su uso como inmunomoduladores | |
| EA201071040A1 (ru) | Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40 | |
| PE20211053A1 (es) | Inhibicion de la proteasa 30 especifica de la ubiquitina (usp30) | |
| UY31554A1 (es) | Nuevos inhibidores de acetil coenzima a carboxilasa y usos en tratamientos de obesidad y diabetes mellitus | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| SV2010003464A (es) | Derivados de pirimida utiles para el tratamiento de condiciones inflamatorias o alergicas | |
| AR074353A1 (es) | Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatititis atopica. | |
| AR045819A1 (es) | Derivados de benzimidazol composiciones que los contienen, preparacion de los mismos y usos de los mismos | |
| BRPI0517425A (pt) | composto ou um sal, solvato, enanciÈmero, diastereÈmero ou mistura de diastereÈmeros do mesmo, composição farmacêutica, uso de composto | |
| AR054790A1 (es) | Metodos para el tratamiento de disfuncion sexual | |
| ES2532084T3 (es) | Composiciones de topiramato y métodos para su uso | |
| ECSP088257A (es) | Derivados de amida | |
| PA8623101A1 (es) | Compuestos farmaceuticamente activos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |